Skip to main content
OpenTrials

Clinical trial condition

Recurrent Small Lymphocytic Lymphoma

Explore clinical trials studying Recurrent Small Lymphocytic Lymphoma. Study availability and eligibility vary by location and protocol.

126 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Small Lymphocytic Lymphoma trial results

Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions
Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

NCT00060424

Conditions
B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details

Related conditions